HITLAB Admin

HITLAB Partners with Immunogenik, Inc. to Accelerate Next-Generation Cancer Therapeutics and U.S. Market Expansion

HITLAB, a global leader in digital health innovation and evidence generation, announced a strategic partnership with Immunogenik, Inc., a biotechnology company developing novel therapeutic platforms for aggressive cancers such as glioblastoma (GBM) and lung cancer brain metastasis.

HITLAB and Cern Corporation Forge Strategic Partnership to Redefine Women’s Health Through Light-Based Innovation

In a groundbreaking collaboration poised to elevate global standards for digital maternal health, HITLAB, a world leader in evidence-based digital-health research, has partnered with BobiHealth, an award-winning pregnancy companion platform recognized as a Top Pregnancy Health Tracking Tool of 2025.

Digital Health Evidence Daily: 11/6/25

HITLAB Partners with Immunogenik, Inc. to Accelerate Next-Generation Cancer Therapeutics and U.S. Market Expansion

HITLAB and Cern Corporation Forge Strategic Partnership to Redefine Women’s Health Through Light-Based Innovation

Digital Health Evidence Daily: 11/5/25

Digital Health Evidence Daily: 11/4/25

Digital Health Evidence Daily: 11/3/25